FGI-106 is a potent broad-spectrum antiviral agent with activity against Ebola virus (EBOV), Rift Valley fever virus, dengue fever virus, hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1), exhibiting EC50 values of 100 nM, 800 nM, 400–900 nM, 200 nM, and 150 nM, respectively.